Budesonide once versus twice‐daily administration: meta‐analysis

Masoli, Matthew; Weatherall, Mark; Holt, Shaun; Beasley, Richard

doi:10.1111/j.1440-1843.2004.00635.x

Cited by 35 publications

(33 citation statements)

References 25 publications

(52 reference statements)

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…2) Where control is achieved at a low dose of inhaled glucocorticosteroids alone, in most patients treatment may be switched to once-daily dosing (Evidence A) [310,311].…”

Section: Stepping Down Treatment When Asthma Is Controlledmentioning

confidence: 99%

Global strategy for asthma management and prevention: GINA executive summary

Bateman

Ss²,

Barnes³

et al. 2008

European Respiratory Journal

2,643

2,301

View full text Add to dashboard Cite

Asthma is a serious health problem throughout the world. During the past two decades, many scientific advances have improved our understanding of asthma and ability to manage and control it effectively. However, recommendations for asthma care need to be adapted to local conditions, resources and services. Since it was formed in 1993, the Global Initiative for Asthma, a network of individuals, organisations and public health officials, has played a leading role in disseminating information about the care of patients with asthma based on a process of continuous review of published scientific investigations. A comprehensive workshop report entitled ''A Global Strategy for Asthma Management and Prevention'', first published in 1995, has been widely adopted, translated and reproduced, and forms the basis for many national guidelines. The 2006 report contains important new themes. First, it asserts that ''it is reasonable to expect that in most patients with asthma, control of the disease can and should be achieved and maintained,'' and recommends a change in approach to asthma management, with asthma control, rather than asthma severity, being the focus of treatment decisions. The importance of the patient-care giver partnership and guided self-management, along with setting goals for treatment, are also emphasised.

show abstract

“…2) Where control is achieved at a low dose of inhaled glucocorticosteroids alone, in most patients treatment may be switched to once-daily dosing (Evidence A) [310,311].…”

Section: Stepping Down Treatment When Asthma Is Controlledmentioning

confidence: 99%

Global strategy for asthma management and prevention: GINA executive summary

Bateman

Ss²,

Barnes³

et al. 2008

European Respiratory Journal

2,643

2,301

View full text Add to dashboard Cite

show abstract

“…14 Parents, as well as some clinicians, are concerned about the use of high doses of ICSs. Whereas some studies have suggested that once-daily ICSs are less effective than twice-daily administered doses, 15,16 we believed that it was essential to evaluate the ability of LABAs to allow once-daily ICSs in children with mild-moderate asthma to test the feasibility of using a lower daily dose in children.…”

mentioning

confidence: 99%

Long-term comparison of 3 controller regimens for mild-moderate persistent childhood asthma: The Pediatric Asthma Controller Trial

Sorkness¹,

Lemanske²,

Mauger³

et al. 2007

Journal of Allergy and Clinical Immunology

268

230

View full text Add to dashboard Cite

“…[125126] If control is achieved, LABA or LTRA may be discontinued or combination therapy shifted to once daily (Evidence D). [125]For significant side effects, consider a change in therapy, reduction in the dose or frequency of ICS (if possible), advise vigorous mouth washing after inhalation, use of spacer (concomitant with MDI devices), and/or use of appropriate local antifungal therapy for severe oral thrush. [127]…”

Section: Approach To Asthma Managementmentioning

confidence: 99%

The Saudi initiative for asthma - 2012 update: Guidelines for the diagnosis and management of asthma in adults and children

et al. 2012

View full text Add to dashboard Cite

This an updated guidelines for the diagnosis and management of asthma, developed by the Saudi Initiative for Asthma (SINA) group, a subsidiary of the Saudi Thoracic Society. The main objective of SINA is to have updated guidelines, which are simple to understand and easy to use by non-asthma specialists, including primary care and general practice physicians. This new version includes updates of acute and chronic asthma management, with more emphasis on the use of Asthma Control Test in the management of asthma, and a new section on “difficult-to-treat asthma.” Further, the section on asthma in children was re-written to cover different aspects in this age group. The SINA panel is a group of Saudi experts with well-respected academic backgrounds and experience in the field of asthma. The guidelines are formatted based on the available evidence, local literature, and the current situation in Saudi Arabia. There was an emphasis on patient–doctor partnership in the management that also includes a self-management plan. The approach adopted by the SINA group is mainly based on disease control as it is the ultimate goal of treatment.

show abstract

Budesonide once versus twice‐daily administration: meta‐analysis

Abstract: In mild to moderate asthma a once-daily budesonide regimen has a similar efficacy to a twice-daily regimen in doses up to 800 microg per day. A once-daily regimen has potential advantages in terms of patient compliance and satisfaction, when used in clinical practice.

Cited by 35 publications

References 25 publications

Global strategy for asthma management and prevention: GINA executive summary

Global strategy for asthma management and prevention: GINA executive summary

Long-term comparison of 3 controller regimens for mild-moderate persistent childhood asthma: The Pediatric Asthma Controller Trial

The Saudi initiative for asthma - 2012 update: Guidelines for the diagnosis and management of asthma in adults and children

Contact Info

Product

Resources

About